Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for reduction of airway edema in mechanically ventilated traumatic brain injury patients
IRCT20250710066438N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexamethasone in Airway edema (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Extubation success rate and Severity of airway edema. Started Aug 2025; status: completed.
02
Drugs
dexamethasone
03
Conditions
Airway edema
Beyond the preview
Go deeper on IRCT20250710066438N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250710066438N1.